Top Markets
#1 Status Status +21.05%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.55%
#3 Fake World Assets Fake World Assets +14.92%
#4 Ontology Gas Ontology Gas +12.78%
#5 GoPlus Security GoPlus Security +12.22%
#6 DMT-NAT DMT-NAT +8.79%
#7 Nillion Nillion +6.92%
#8 Provenance Blockchain Provenance Blockchain +6.68%
#9 Janction Janction +6.46%
#10 Bedrock Bedrock +5.82%
Coin of the day
Status Status
Настройки
Язык
Pусский
Валюта
USD
Тема
Renalytix Plc Renalytix Plc

Renalytix Plc

RNLX
Ранг среди акций #33998
Renalytix Plc, established in New York in 2018 and known as Renalytix AI plc... Renalytix Plc, established in New York in 2018 and known as Renalytix AI plc until its name change in June 2021, focuses on creating artificial intelligence-driven in vitro diagnostic tools for kidney ailments. Its primary product, KidneyIntelX, is an advanced diagnostic system that utilizes an AI-powered algorithm. This algorithm integrates multiple data sources, including scientifically validated blood markers, genetic predispositions, and individual patient information from electronic health records, to produce a distinct risk score for kidney disease. The company's technology is applied in various areas: identifying and predicting the course of kidney disease, informing clinical treatment, selecting patients for pharmaceutical trials, and discovering new therapeutic targets. Renalytix has formed several strategic collaborations, such as licensing agreements with Mount Sinai Health System for AI-assisted kidney disease diagnosis, with Joslin Diabetes Center, Inc. for developing biomarker-based kidney disease prediction products, and with Kantaro Biosciences LLC for laboratory tests to detect SARS-CoV-2 antibodies. Furthermore, it has partnered with Atrium Health, Wake Forest Baptist Health, and Wake Forest School of Medicine to introduce an innovative clinical care model aimed at improving kidney health outcomes and preventing disease advancement and failure in vulnerable populations.
Цена акции
$0.1502
Последняя синхронизация: 2024-11-04
Рыночная капитализация
$6.43M
Изменение (1 день)
-5.45%
Изменение (1 год)
0.00%
Страна
US
Торговля Renalytix Plc (RNLX)

Категория

Healthcare
Операционная маржа для Renalytix Plc (RNLX)
Операционная маржа на August 2026 TTM: -1,293.49%
Согласно последним финансовым отчетам и цене акций Renalytix Plc, текущая операционная маржа (TTM) составляет -1,293.49%. В конце 2023 она составила -1,244.64%.
История операционной маржи Renalytix Plc с 2018 по 2026
Операционная маржа на конец каждого года
Год Операционная маржа Изменить
2026 (TTM) -1,293.49% 0.00%
2024 -1,293.49% 3.92%
2023 -1,244.64% -35.57%
2022 -1,931.72% -11.68%
2021 -2,187.19% 0.00%
2020 0.00% 0.00%
2019 0.00% 0.00%
2018 0.00% 0.00%
Операционная маржа для аналогичных компаний или конкурентов
Компания Операционная маржа Разница в операционной марже Страна
GE HealthCare Technologies Inc. GE HealthCare Technologies Inc.
GE HealthCare Technologies Inc.
GEHC.US
12.70% -100.01%
US
Pro Medicus Limited Pro Medicus Limited
Pro Medicus Limited
PME.AX
74.17% -100.06%
AU
BrightSpring Health Services, Inc. Common Stock BrightSpring Health Services, Inc. Common Stock
BrightSpring Health Services, Inc. Common Stock
BTSG.US
3.33% -100.00%
US
Tempus AI, Inc. Tempus AI, Inc.
Tempus AI, Inc.
TEM.US
-19.76% -99.98%
US
Signify Health, Inc. Signify Health, Inc.
Signify Health, Inc.
SGFY.US
0.00% -
US
Что такое операционная маржа компании?
Операционная маржа — это ключевой показатель прибыльности компании. Более высокая операционная маржа обычно означает, что компания может продавать свои товары или услуги значительно дороже их себестоимости. Она рассчитывается путем деления прибыли компании на её выручку.